Medotilin in the rehabilitation system for patients with acute cerebrovascular accidents

Authors: Teshchuk V., Teshchuk N., Dunaj О.

Military-medical Clinical Centre of South Region, Odessa, Ukraine


Abstract

The article presents the results of a comprehensive clinical and neurological examination of 57 patients, who underwent treatment in the angioneurological department of the Neurosurgery and Neurology Clinic of the Military Medical Clinical Center of the Southern Region of Ukraine. In this article, there is analyzed the impact of Medotilin (in a dose of 4.0 ml – 1.000 mg intramuscularly, once a day, for 30 days) on cerebral hemodynamics and bioelectric activity of the brain in patients with acute cerebrovascular accident (ACVA) by ischemic type. It was found that Medotilin in this group of patients improves cerebral hemodynamics and causes reorganization of the bioelectric activity of the brain. The type of reorganization is determined by hemispheric localization of ACVA. Positive impact of Medotilin on cerebral hemodynamics and bioelectric activity of the brain in patients, who have suffered ischemic ACVA, gives reason to recommend the wider use of Medotilin in the system of rehabilitation in this group of patients.

Keywords: acute cerebrovascular accident; ischemic stroke; Medotilin; rehabilitation; cerebral hemodynamics; bioelectric activity of the brain.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design